<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
VCYT
Veracyte
$
()


  • Veracyte study shows Decipher Prostate Test is prognostic

    4/22/2024 - 08:51am
  • Veracyte files automatic mixed securities shelf

    2/29/2024 - 16:44pm
  • Cathie Wood's ARK Investment bought 154K shares of Veracyte today

    2/26/2024 - 20:04pm
  • Veracyte price target raised by $3 at Needham, here's why

    2/23/2024 - 07:17am
  • Fly Intel: After-Hours Movers

    2/22/2024 - 19:19pm
  • Veracyte backs FY24 revenue view of $394M-$402M, consensus $393.3M

    2/22/2024 - 16:29pm
  • Veracyte reports Q4 GAAP EPS (39c) vs. (5c) last year

    2/22/2024 - 16:29pm
  • Veracyte to acquire C2i Genomics for $70M upfront

    1/8/2024 - 08:37am
  • Veracyte sees FY24 revenue $394M-$402M, consensus $391.5M

    1/8/2024 - 08:35am
  • Veracyte sees FY23 revenue $358M-$359M, consensus $352.78M

    1/8/2024 - 08:33am
  • Veracyte sees Q4 revenue $95M-$96M, consensus $89.91M

    1/8/2024 - 08:32am
  • Veracyte price target lowered to $30 from $35 at Needham

    11/8/2023 - 09:09am
  • Veracyte raises FY23 revenue view to $352M-$354M from $342M-$350M

    11/7/2023 - 16:43pm
  • Veracyte reports Q3 EPS (41c), consensus (15c)

    11/7/2023 - 16:42pm
  • Veracyte enters In Vitro diagnostic agreement with Illumina

    11/7/2023 - 16:01pm
dynamic_feed Breaking News